Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för John D Weil. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att John D Weil har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:AHPI / Allied Healthcare Product Inc. | Director | 0 |
US:BWINB / Baldwin & Lyons, Inc. | Director, 10% Owner | 203 767 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av John D Weil. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av John D Weil som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2021-11-30 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
S - Sale | −7 514 | 0 | −100,00 | 8,06 | −60 537 | ||
2021-11-30 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
S - Sale | −59 101 | 0 | −100,00 | 8,47 | −500 408 | ||
2021-11-30 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
S - Sale | −69 249 | 25 178 | −73,34 | 8,44 | −584 254 | 212 427 | |
2021-11-30 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Option to purchase common stock |
A - Award | 750 | 750 | |||||
2021-11-15 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Option to purchase common stock |
A - Award | 750 | 750 | |||||
2020-11-16 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Option to purchase common stock |
A - Award | 750 | 750 | |||||
2020-10-28 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
J - Other | −413 | 7 514 | −5,21 | ||||
2020-09-15 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
J - Other | −137 736 | 0 | −100,00 | ||||
2019-11-12 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Option to purchase common stock |
A - Award | 750 | 750 | |||||
2018-11-09 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Option (right to buy) |
A - Award | 750 | 750 | |||||
2018-10-10 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
J - Other | −59 272 | 60 520 | −49,48 | ||||
2018-08-21 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
J - Other | −357 304 | 137 735 | −72,18 | ||||
2018-08-21 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
J - Other | 36 936 | 90 514 | 68,94 | ||||
2017-11-14 |
|
4 | AHPH |
ALLIED HEALTHCARE PRODUCTS INC
Option (right to buy) |
A - Award | 750 | 750 | |||||
2016-11-14 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Option (right to buy) |
A - Award | 1 500 | 1 500 | |||||
2016-01-25 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
J - Other | 52 972 | 107 154 | 97,77 | ||||
2015-11-16 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Option (right to buy) |
A - Award | 1 500 | 1 500 | |||||
2015-03-25 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
G - Gift | −5 000 | 203 767 | −2,40 | 23,61 | −118 050 | 4 810 939 | |
2015-03-19 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −80 | 4 988 | −1,58 | 23,43 | −1 874 | 116 871 | |
2015-03-17 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −2 | 5 068 | −0,04 | 23,40 | −47 | 118 608 | |
2015-03-17 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −1 | 5 070 | −0,02 | 23,40 | −23 | 118 638 | |
2015-03-13 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −18 | 5 071 | −0,35 | 23,40 | −421 | 118 661 | |
2015-03-13 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −2 | 5 089 | −0,04 | 23,40 | −47 | 119 083 | |
2015-03-05 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −7 | 5 091 | −0,14 | 23,42 | −164 | 119 225 | |
2015-03-02 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −4 | 5 098 | −0,08 | 23,31 | −93 | 118 835 | |
2015-03-02 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −4 599 | 34 781 | −11,68 | 23,27 | −107 032 | 809 455 | |
2014-12-23 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −6 | 5 102 | −0,12 | 26,26 | −158 | 133 971 | |
2014-12-19 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −1 189 | 208 767 | −0,57 | 26,25 | −31 217 | 5 481 094 | |
2014-12-19 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −1 | 5 108 | −0,02 | 26,25 | −26 | 134 085 | |
2014-12-16 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
G - Gift | −5 700 | 209 956 | −2,64 | 25,42 | −144 866 | 5 336 032 | |
2014-12-12 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
P - Purchase | 10 000 | 54 182 | 22,63 | 1,45 | 14 500 | 78 564 | |
2014-12-12 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
P - Purchase | 700 | 44 182 | 1,61 | 1,43 | 1 001 | 63 180 | |
2014-12-11 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −2 | 5 109 | −0,04 | 26,25 | −52 | 134 111 | |
2014-12-11 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −7 | 5 111 | −0,14 | 26,35 | −184 | 134 652 | |
2014-12-11 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −1 046 | 215 656 | −0,48 | 26,25 | −27 458 | 5 660 970 | |
2014-11-19 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
P - Purchase | 3 300 | 43 482 | 8,21 | 1,50 | 4 950 | 65 223 | |
2014-11-19 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
P - Purchase | 108 | 40 182 | 0,27 | 1,50 | 162 | 60 273 | |
2014-11-17 |
|
4/A | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Option (right to buy) |
A - Award | 1 500 | 1 500 | |||||
2014-11-14 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −600 | 216 702 | −0,28 | 26,56 | −15 938 | 5 756 320 | |
2014-11-14 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −3 354 | 217 302 | −1,52 | 25,50 | −85 539 | 5 542 005 | |
2014-11-14 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −1 646 | 1 567 | −51,23 | 25,50 | −41 979 | 39 964 | |
2014-11-14 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Option (Right to buy) |
A - Award | 1 500 | 1 500 | |||||
2014-06-25 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −400 | 39 357 | −1,01 | 26,10 | −10 440 | 1 027 218 | |
2014-06-24 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −300 | 39 757 | −0,75 | 26,10 | −7 830 | 1 037 658 | |
2014-06-24 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −3 000 | 40 057 | −6,97 | 26,15 | −78 455 | 1 047 555 | |
2014-06-11 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −62 | 43 057 | −0,14 | 26,10 | −1 618 | 1 123 788 | |
2014-06-11 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −1 461 | 43 119 | −3,28 | 26,10 | −38 134 | 1 125 475 | |
2014-06-03 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −7 | 44 580 | −0,02 | 26,10 | −183 | 1 163 538 | |
2014-05-30 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −3 200 | 44 587 | −6,70 | 26,29 | −84 141 | 1 172 371 | |
2014-05-28 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −5 000 | 47 787 | −9,47 | 26,58 | −132 912 | 1 270 288 | |
2014-05-28 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −2 300 | 220 656 | −1,03 | 26,10 | −60 030 | 5 759 122 | |
2014-05-23 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −3 100 | 222 956 | −1,37 | 26,26 | −81 406 | 5 854 802 | |
2014-05-23 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −289 | 226 056 | −0,13 | 26,26 | −7 589 | 5 936 231 | |
2014-05-21 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −3 832 | 226 345 | −1,66 | 26,25 | −100 598 | 5 942 032 | |
2014-05-21 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
P - Purchase | 1 000 | 5 000 | 25,00 | 2,15 | 2 150 | 10 750 | |
2014-05-12 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
A - Award | 1 567 | 3 213 | 95,20 | ||||
2014-03-26 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −3 854 | 204 285 | −1,85 | 26,03 | −100 301 | 5 316 558 | |
2014-03-26 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −4 146 | 1 646 | −71,58 | 26,03 | −107 900 | 42 837 | |
2014-03-25 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −749 | 208 139 | −0,36 | 26,10 | −19 549 | 5 432 428 | |
2014-03-25 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −3 280 | 208 888 | −1,55 | 26,10 | −85 608 | 5 451 977 | |
2014-03-21 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −300 | 212 168 | −0,14 | 26,10 | −7 830 | 5 537 585 | |
2014-03-21 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −800 | 212 468 | −0,38 | 26,15 | −20 919 | 5 555 783 | |
2014-03-21 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −3 473 | 213 268 | −1,60 | 26,10 | −90 645 | 5 566 295 | |
2014-03-18 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
G - Gift | −10 000 | 230 177 | −4,16 | 26,09 | −260 900 | 6 005 318 | |
2014-03-14 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
G - Gift | −5 000 | 5 792 | −46,33 | 25,95 | −129 750 | 150 302 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −3 749 | 39 380 | −8,69 | 23,75 | −89 056 | 935 456 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −201 | 81 456 | −0,25 | 23,75 | −4 774 | 1 934 580 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −300 | 81 657 | −0,37 | 23,78 | −7 133 | 1 941 428 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −84 | 81 957 | −0,10 | 23,75 | −1 995 | 1 946 479 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −122 | 82 041 | −0,15 | 23,76 | −2 899 | 1 949 655 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −2 700 | 82 163 | −3,18 | 23,86 | −64 418 | 1 960 278 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −500 | 84 863 | −0,59 | 23,80 | −11 898 | 2 019 315 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −1 000 | 85 363 | −1,16 | 23,90 | −23 899 | 2 040 116 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −2 501 | 86 363 | −2,81 | 23,82 | −59 571 | 2 057 054 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −506 | 88 864 | −0,57 | 23,76 | −12 022 | 2 111 231 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −88 | 89 370 | −0,10 | 23,75 | −2 090 | 2 122 538 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −200 | 89 458 | −0,22 | 23,76 | −4 751 | 2 125 075 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −2 336 | 89 658 | −2,54 | 23,75 | −55 490 | 2 129 763 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −164 | 91 994 | −0,18 | 23,76 | −3 896 | 2 185 575 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −1 900 | 92 158 | −2,02 | 23,82 | −45 258 | 2 195 194 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −400 | 94 058 | −0,42 | 23,75 | −9 500 | 2 233 878 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −3 | 94 458 | 0,00 | 23,76 | −71 | 2 244 322 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −224 | 94 461 | −0,24 | 23,75 | −5 320 | 2 243 449 | |
2014-01-28 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −449 | 94 685 | −0,47 | 23,81 | −10 691 | 2 254 516 | |
2013-12-27 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −1 000 | 95 134 | −1,04 | 23,35 | −23 355 | 2 221 826 | |
2013-12-27 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −1 512 | 96 134 | −1,55 | 22,93 | −34 667 | 2 204 141 | |
2013-12-27 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −1 000 | 97 646 | −1,01 | 22,81 | −22 808 | 2 227 149 | |
2013-12-27 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −91 | 98 646 | −0,09 | 22,81 | −2 076 | 2 250 313 | |
2013-12-27 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −735 | 98 737 | −0,74 | 22,75 | −16 721 | 2 246 267 | |
2013-12-27 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
J - Other | 22 026 | 99 472 | 28,44 | ||||
2013-12-27 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
J - Other | 4 338 | 77 446 | 5,93 | ||||
2013-12-27 |
|
5 | BWINB |
BALDWIN & LYONS INC
Class A Common Stock |
J - Other | 736 | 13 080 | 5,96 | ||||
2013-12-24 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
G - Gift | −7 700 | 240 177 | −3,11 | 26,86 | −206 822 | 6 451 154 | |
2013-12-24 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −3 492 | 216 741 | −1,59 | 27,21 | −95 018 | 5 897 588 | |
2013-12-20 |
|
5 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
J - Other | 13 421 | 239 587 | 5,93 | ||||
2013-12-11 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −2 100 | 220 233 | −0,94 | 27,22 | −57 164 | 5 994 940 | |
2013-12-09 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −5 900 | 31 680 | −15,70 | 27,24 | −160 698 | 862 865 | |
2013-12-09 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −326 | 37 580 | −0,86 | 27,00 | −8 803 | 1 014 792 | |
2013-12-05 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −300 | 37 906 | −0,79 | 27,04 | −8 112 | 1 024 978 | |
2013-12-04 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −9 903 | 10 792 | −47,85 | 27,62 | −273 553 | 298 110 | |
2013-12-02 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −13 191 | 34 781 | −27,50 | 27,22 | −359 025 | 946 648 | |
2013-11-27 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −4 587 | 47 972 | −8,73 | 26,95 | −123 600 | 1 292 644 | |
2013-11-27 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −5 700 | 52 559 | −9,78 | 26,85 | −153 064 | 1 411 383 | |
2013-11-25 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −5 604 | 58 259 | −8,78 | 26,64 | −149 283 | 1 551 944 | |
2013-11-25 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −762 | 63 863 | −1,18 | 26,51 | −20 199 | 1 692 874 | |
2013-11-21 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −37 | 64 625 | −0,06 | 26,64 | −986 | 1 721 933 | |
2013-11-19 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −3 500 | 64 662 | −5,13 | 26,52 | −92 837 | 1 715 153 | |
2013-11-19 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −1 946 | 68 162 | −2,78 | 26,59 | −51 750 | 1 812 632 | |
2013-11-18 |
|
4/A | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Option (right to buy) |
A - Award | 1 500 | 1 500 | |||||
2013-11-18 |
|
4/A | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
J - Other | 226 166 | 226 166 | |||||
2013-11-15 |
|
4/A | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −800 | 70 108 | −1,13 | 26,52 | −21 212 | 1 858 928 | |
2013-11-15 |
|
4/A | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −2 200 | 70 908 | −3,01 | 26,81 | −58 974 | 1 900 781 | |
2013-11-15 |
|
4/A | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
J - Other | 73 108 | 73 108 | |||||
2013-11-15 |
|
4/A | BWINB |
BALDWIN & LYONS INC
Class A Common Stock |
J - Other | 12 344 | 12 344 | |||||
2013-08-27 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −464 | 20 695 | −2,19 | 24,70 | −11 461 | 511 166 | |
2013-08-23 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −5 253 | 21 159 | −19,89 | 24,75 | −130 033 | 523 770 | |
2013-08-23 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −5 253 | 21 159 | −19,89 | 24,75 | −130 033 | 523 770 | |
2013-05-09 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
A - Award | 1 646 | 26 412 | 6,65 | ||||
2012-12-19 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −3 500 | 247 877 | −1,39 | 23,12 | −80 931 | 5 731 685 | |
2012-12-19 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −2 640 | 251 377 | −1,04 | 23,00 | −60 726 | 5 782 249 | |
2012-12-14 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −6 | 254 017 | 0,00 | 23,00 | −138 | 5 842 391 | |
2012-12-14 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
S - Sale | −266 | 254 023 | −0,10 | 23,00 | −6 118 | 5 842 529 | |
2012-11-13 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Option (right to buy) |
A - Award | 1 500 | 1 500 | |||||
2012-11-13 |
|
4/A | BWIN |
BALDWIN & LYONS INC
Class B Common Stock |
J - Other | 263 | 5 118 | 5,42 | ||||
2012-11-13 |
|
4/A | BWIN |
BALDWIN & LYONS INC
Class A Common Stock |
J - Other | 45 | 865 | 5,49 | ||||
2012-09-27 |
|
4 | BWINA |
BALDWIN & LYONS INC
Class A Common Stock |
A - Award | 10 950 | 12 578 | 672,60 | ||||
2012-09-27 |
|
4 | BWINA |
BALDWIN & LYONS INC
Class A Common Stock |
J - Other | −10 950 | 43 189 | −20,23 | ||||
2012-07-05 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
J - Other | −75 678 | 222 333 | −25,39 | ||||
2012-05-11 |
|
4 | BWINB |
BALDWIN & LYONS INC
Class B Common Stock |
J - Other | −22 026 | 298 011 | −6,88 | ||||
2012-05-09 |
|
4 | BWIN |
BALDWIN & LYONS INC
Class B Common Stock |
A - Award | 1 829 | 24 766 | 7,97 | ||||
2012-01-10 |
|
4 | BWIN |
BALDWIN & LYONS INC
Class B Common Stock |
J - Other | 4 855 | 4 855 | |||||
2012-01-10 |
|
4 | BWIN |
BALDWIN & LYONS INC
Class A Common Stock |
J - Other | 820 | 820 | |||||
2012-01-10 |
|
4 | BWIN |
BALDWIN & LYONS INC
Class B Common Stock |
J - Other | −692 003 | 320 037 | −68,38 | ||||
2012-01-10 |
|
4 | BWIN |
BALDWIN & LYONS INC
Class A Common Stock |
J - Other | −117 069 | 54 139 | −68,38 | ||||
2012-01-10 |
|
4 | BWIN |
BALDWIN & LYONS INC
Class B Common Stock |
J - Other | 144 612 | 254 289 | 131,85 | ||||
2012-01-10 |
|
4 | BWIN |
BALDWIN & LYONS INC
Class A Common Stock |
J - Other | 24 462 | 72 712 | 50,70 | ||||
2012-01-10 |
|
4 | BWIN |
BALDWIN & LYONS INC
Class B Common Stock |
J - Other | 38 206 | 38 206 | |||||
2012-01-10 |
|
4 | BWIN |
BALDWIN & LYONS INC
Class A Common Stock |
J - Other | 6 462 | 6 462 | |||||
2012-01-10 |
|
4 | BWIN |
BALDWIN & LYONS INC
Class B Common Stock |
J - Other | 52 537 | 52 787 | 21 014,80 | ||||
2012-01-10 |
|
4 | BWIN |
BALDWIN & LYONS INC
Class A Common Stock |
J - Other | 8 878 | 8 878 | |||||
2012-01-10 |
|
4 | BWIN |
BALDWIN & LYONS INC
Class B Common Stock |
J - Other | 9 559 | 22 937 | 71,45 | ||||
2012-01-10 |
|
4 | BWIN |
BALDWIN & LYONS INC
Class A Common Stock |
J - Other | 1 628 | 1 628 | |||||
2012-01-06 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
J - Other | 15 028 | 15 028 | |||||
2012-01-06 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
J - Other | −2 140 678 | 990 079 | −68,38 | ||||
2012-01-06 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
J - Other | 447 361 | 447 361 | |||||
2012-01-06 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
J - Other | 118 203 | 118 203 | |||||
2012-01-06 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
J - Other | 162 555 | 188 855 | 618,08 | ||||
2012-01-06 |
|
4 | AHPI |
ALLIED HEALTHCARE PRODUCTS INC
Common Stock |
J - Other | 29 574 | 40 074 | 281,66 |